Duterte’s PSG first to be vaccinated against COVID-19—AFP | Inquirer News

Duterte’s PSG first to be vaccinated against COVID-19—AFP

By: - Reporter / @KAguilarINQ
/ 02:58 PM December 28, 2020

Duterte at the PSG Change of Command Ceremony

FILE PHOTO — President Rodrigo Roa Duterte salutes outgoing Presidential Security Group (PSG) Commander Jose Niembra and incoming PSG Commander Colonel Jesus Durante III during the PSG Change of Command ceremony at the PSG Compound in Malacañang Park, Manila on February 25, 2020. REY BANIQUET/PRESIDENTIAL PHOTO

MANILA, Philippines — Members of the Presidential Security Group (PSG) were the first among military personnel to be vaccinated against the COVID-19, the Armed Forces of the Philippines (AFP) confirmed Monday.

“As the unit primarily tasked to protect and secure the highest official of the land, the PSG will have to ensure that the President is safe from all threats—including COVID-19,” AFP spokesperson Maj. Gen. Edgar Arevalo said in a statement.

Article continues after this advertisement

Arevalo noted that the AFP is “not privy with the arrangements as to how the vaccines were obtained.”

FEATURED STORIES

“Because the safety of the President equates to national well-being, that security posture should necessarily include protecting the Commander-in-Chief from contracting the deadly virus from those he is constantly exposed to as the members of his security detail,” Arevalo further said.

It was Interior Secretary Eduardo Año who earlier bared that members of the PSG along with some Cabinet members were already vaccinated against the new coronavirus.

Article continues after this advertisement

During a televised speech over the weekend, President Rodrigo Duterte said several military personnel was already inoculated with a vaccine against COVID-19 developed by China’s Sinopharm.

Article continues after this advertisement

PSG Commander Brig. Gen. Jesus Durante III defended the move to inoculate their members, saying this was to ensure that they themselves were not a threat to the President’s health and safety.

Article continues after this advertisement

“National security imposes the protection of the President being the Commander-in-Chief from all forms of threat, especially COVID-19, in order to preserve the stability of our nation. It is PSG’s primordial task to ensure that we have a healthy President serving our fellow Filipinos every day,” Durante said in a statement.

“We are in a state of war, a war against COVID-19. War compels us to survive as what we are now doing in this pandemic. As such, PSG exploits all means in order to deliver its mandate as what is highly expected of them by the Filipino people,” he added.

Article continues after this advertisement

The Philippines’ Food and Drug Administration has yet to authorize the use of any COVID-19 vaccine in the country.

Despite this, Malacañang said it is not against the law to be inoculated with a vaccine even if it is not yet registered with the country’s regulators.

CFC
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: AFP, COVID-19, COVID-19 Vaccine, Military, PSG, Sinopharm

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.